PhaseRx Analysis
PhaseRx is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of PhaseRx delisted stock analysis is to determine its intrinsic value, which is an estimate of what PhaseRx is worth, separate from its market price. There are two main types of PhaseRx's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PhaseRx's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PhaseRx's stock to identify patterns and trends that may indicate its future price movements.
The PhaseRx stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. PhaseRx is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. PhaseRx Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PhaseRx's ongoing operational relationships across important fundamental and technical indicators.
PhaseRx |
PhaseRx Stock Analysis Notes
About 52.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.19. PhaseRx had not issued any dividends in recent years. PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. On December 11, 2017, PhaseRx, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. PhaseRx operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 10 people. To find out more about PhaseRx contact Robert Overell at 206-805-6300 or learn more at http://www.phaserx.com.PhaseRx Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. PhaseRx's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding PhaseRx or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| PhaseRx is not yet fully synchronised with the market data | |
| PhaseRx has some characteristics of a very speculative penny stock | |
| PhaseRx has a very high chance of going through financial distress in the upcoming years | |
| PhaseRx has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (13.89 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PhaseRx currently holds about 5.26 M in cash with (12.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45. |
PhaseRx Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PhaseRx's market, we take the total number of its shares issued and multiply it by PhaseRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PhaseRx to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in PhaseRx Stock
If you are still planning to invest in PhaseRx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PhaseRx's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |